Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $325,322 - $440,693
5,237 Added 33.26%
20,985 $1.5 Million
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $1.04 Million - $1.21 Million
15,748 New
15,748 $1.11 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $474,935 - $628,980
7,034 Added 154.19%
11,596 $789,000
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $157,477 - $183,567
-2,135 Reduced 31.88%
4,562 $372,000
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $479,639 - $580,094
6,697 New
6,697 $496,000
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $1.37 Million - $1.9 Million
-4,855 Reduced 36.9%
8,302 $2.36 Million
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $4.25 Million - $5.92 Million
13,157 New
13,157 $4.56 Million
Q4 2021

Feb 14, 2022

SELL
$456.15 - $525.06 $249,970 - $287,732
-548 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $417,288 - $505,469
-938 Reduced 63.12%
548 $266,000
Q2 2021

Aug 16, 2021

BUY
$387.35 - $450.26 $575,602 - $669,086
1,486 New
1,486 $669,000
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $479,166 - $625,953
-1,523 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$246.9 - $321.87 $620,953 - $809,503
-2,515 Reduced 62.28%
1,523 $484,000
Q3 2020

Nov 16, 2020

BUY
$232.22 - $282.96 $282,611 - $344,362
1,217 Added 43.14%
4,038 $1 Million
Q2 2020

Aug 17, 2020

BUY
$185.43 - $279.56 $523,098 - $788,638
2,821 New
2,821 $745,000
Q1 2020

May 15, 2020

SELL
$161.17 - $221.51 $1.37 Million - $1.88 Million
-8,478 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$189.68 - $222.09 $1.61 Million - $1.88 Million
8,478 New
8,478 $1.86 Million
Q3 2019

Nov 14, 2019

SELL
$183.56 - $216.72 $1.52 Million - $1.8 Million
-8,286 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$188.72 - $215.43 $1.28 Million - $1.46 Million
6,786 Added 452.4%
8,286 $1.73 Million
Q1 2019

May 15, 2019

BUY
$136.09 - $200.44 $204,135 - $300,660
1,500 New
1,500 $298,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.